Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Crossref
2. Predictors for dose reduction of antiviral therapy in older patients infected with hepatitis C virus: a meta-regression analysis
- H. Zhou
- H. Luo
- S. Xiao
- H. Wang
- G. Gong
4. Determinant Factors of the Direct Medical Costs Associated with Genotype 1 Hepatitis C Infection in Treatment-Experienced Patients
- Essè Ifèbi Hervé Akpo
- Urbano Sbarigia
- George Wan
- Joris Kleintjens
5. Efficacy and safety of peginterferon plus ribavirin for patients aged ≥ 65 years with chronic hepatitis C: A systematic review and meta-analysis
- Zongguo Yang
- Liping Zhuang
- Lei Yang
- Cheng Liu
- Yunfei Lu
- Qingnian Xu
- Xiaorong Chen
- Liang Chen
6. Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens
- Umberto Vespasiani-Gentilucci
7. Effectiveness of Ledipasvir-Sofosbuvir 12 Weeks After Hepatitis C Virus Genotype 1 Infection and the Factors Associated With Sustained Virologic Response: A Retrospective Study
- Ismaeel A Alshoaibi
- Abdullah Al-Gamli
- Mohammed Abdullah
- Basheer Abdo
- Khaled H Alzanen
- Mohammed Alhakamy
- Mamoon Al-Namer
- Faisal Ahmed
- Munther Tamesh
- Wadhah Mahdi
- Zeyad Abdo
- Marwa Mohammed
8. Treating hepatitis C in the elderly: the future is near?
- Fabio Conti
- Giovanni Vitale
- Pietro Andreone
9. Factors associated with treatment interruption for hepatitis C
- Luciana Oliveira de Rezende Melo
- Denise Leite Maia Monteiro
- Nádia Cristina Pinheiro Rodrigues
10. Changing of HCV Clade Pattern in Iran; the Possible Means for Something Good
- Muhammad Sohail Afzal
- Sadia Anjum
- Najam us Sahar Sadaf Zaidi
11. Optimal management of patients with chronic hepatitis C and comorbidities
- Vincenzo Boccaccio
- Savino Bruno